🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Ocular Therapeutix, Inc.

OCUL Healthcare
$5.57 $-0.29 (-4.95%)
Market Cap: $1.23 B
Gurus Holding
3
Popularity Rank
#2736
% of Shares Held
0.88%
Net Activity (Q3 2026)
-$25.7 M

Guru Ownership Trend

Guru Analysis for Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix, Inc. (OCUL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $10.81 M.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $25.7 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 42.8%. Conversely, Steven Cohen reduced exposure by 91.4%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$2.51 M
Total Buy Value
New Buys 0
Additions 2
-$28.21 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Ocular Therapeutix, Inc. (OCUL)

Major holders include Cliff Asness ($8.56 M), Renaissance Technologies (RenTech) ($4.15 M), Steven Cohen ($2.17 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.94 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $25.7 M, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited OCUL. The total reported sell value was $28.21 M.

Yes, 0 managers opened new positions in OCUL, and 2 increased their existing holdings. The total reported buy value was $2.51 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 17.4% 1,115,582 $8.56 M Q3 2026
0.01% Add 42.8% 540,900 $4.15 M Q3 2026
0.00% Reduce -91.4% 283,555 $2.17 M Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form